| Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade JJ Ishizuka, RT Manguso, CK Cheruiyot, K Bi, A Panda, A Iracheta-Vellve, ... Nature 565 (7737), 43-48, 2019 | 503 | 2019 |
| Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity GK Griffin, J Wu, A Iracheta-Vellve, JC Patti, J Hsu, T Davis, D Dele-Oni, ... Nature 595 (7866), 309-314, 2021 | 215 | 2021 |
| In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer J Dubrot, PP Du, SK Lane-Reticker, EA Kessler, AJ Muscato, A Mehta, ... Nature Immunology 23 (10), 1495-1506, 2022 | 72 | 2022 |
| Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome MG Durrant, A Fanton, J Tycko, M Hinks, SS Chandrasekaran, NT Perry, ... Nature biotechnology 41 (4), 488-499, 2023 | 68 | 2023 |
| In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma J Dubrot, SK Lane-Reticker, EA Kessler, A Ayer, G Mishra, CH Wolfe, ... Immunity 54 (3), 571-585. e6, 2021 | 59 | 2021 |
| Targeting TBK1 to overcome resistance to cancer immunotherapy Y Sun, O Revach, S Anderson, EA Kessler, CH Wolfe, A Jenney, CE Mills, ... Nature 615 (7950), 158-167, 2023 | 37 | 2023 |
| Glioma synapses recruit mechanisms of adaptive plasticity KR Taylor, T Barron, A Hui, A Spitzer, B Yalçin, AE Ivec, AC Geraghty, ... Nature 623 (7986), 366-374, 2023 | 33 | 2023 |
| Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders L Zhou, Z Zeng, AM Egloff, F Zhang, F Guo, KM Campbell, P Du, J Fu, ... Journal for immunotherapy of cancer 10 (1), 2022 | 20 | 2022 |
| Large-scale discovery of recombinases for integrating DNA into the human genome MG Durrant, A Fanton, J Tycko, M Hinks, SS Chandrasekaran, NT Perry, ... BioRxiv, 2021.11. 05.467528, 2021 | 13 | 2021 |
| Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasion SC Shvefel, JA Pai, Y Cao, LR Pal, R Levy, W Yao, K Cheng, M Zemanek, ... bioRxiv, 2023 | 1 | 2023 |
| GLIOMA SYNAPSES RECRUIT MECHANISMS OF ADAPTIVE PLASTICITY K Taylor, T Barron, H Zhang, A Hui, G Hartmann, L Ni, H Venkatesh, P Du, ... NEURO-ONCOLOGY 24, 25-25, 2022 | | 2022 |
| CNSC-17. GLIOMA SYNAPSES RECRUIT MECHANISMS OF ADAPTIVE PLASTICITY K Taylor, T Barron, H Zhang, A Hui, G Hartmann, L Ni, H Venkatesh, P Du, ... Neuro-Oncology 24 (Supplement_7), vii25-vii25, 2022 | | 2022 |
| Pathogenic or benign? PP Du, K Liu, MC Bassik, GT Hess Nature Biotechnology 40 (6), 834-836, 2022 | | 2022 |
| 635P Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer HM Lin, B Mak, K Huynh, EM Kwan, H Fettke, B Tran, ID Davis, KL Mahon, ... Annals of Oncology 32, S666-S667, 2021 | | 2021 |
| 596P Impact of combined lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) B Mak, HM Lin, EM Kwan, H Fettke, B Tran, ID Davis, KL Mahon, ... Annals of Oncology 32, S642-S643, 2021 | | 2021 |
| Abstract PO009: Epigenetic silencing by SETDB1 represses tumor-cell intrinsic immunogenicity J Wu, A Iracheta-Vellve, J Patti, J Hsu, T Davis, D Dele-Oni, P Du, ... Cancer Immunology Research 9 (2_Supplement), PO009-PO009, 2021 | | 2021 |
| SCAR (Selective CRISPR Antigen Removal) vector system expands cancer immunology discovery with in vivo functional genomics J Dubrot, SK Lane-Reticker, E Kessler, C Wolfe, A Mahapatra, P Du, ... Cancer Research 80 (16_Supplement), 5866-5866, 2020 | | 2020 |
